Table 2.

Gene expression datasets used in this study.

Groups	GEO accession	Platform	Sample	Condition 1	Condition 2
Microarray Data
	GSE1739 (30)	GPL201	PBMCs	Controls (n = 4)	SARS-CoV-1 (n = 10)
	GSE17156 (31)	GPL571	Whole blood	Controls (n = 17)	Influenza H3N2 (n = 17)
	GSE17156 (31)	GPL571	Whole blood	Controls (n = 20)	Respiratory syncytial virus (n = 20)
RNA-seq Data
	PRJNA646224 (32)	GPL21697	Lung autopsies	Controls (n = 10)	Lung autopsies (n = 9)
	EGAS00001004503 (33)	GPL24676	Whole blood	Controls (n = 10)	COVID-19 (n = 39, 19 mild and 20 severe)
	GSE157103 (34)	GPL24676	Leukocytes from whole blood	Controls (n = 10)	moderate COVID-19 (n = 51), severe COVID-19 (n = 49, 12 non-critical and 37 critical)
	Panousis et al. (35)	GPL11154	Whole blood	Controls (n = 58)	Active systemic lupus erythematosus (n = 79)
Single-cell RNA-seq Data
	GSE150728 (36)	GPL24676	Peripheral blood mononuclear cells	Healthy (n = 6)	Severe COVID-19 (n = 7)

SARS-CoV, Severe acute respiratory syndrome coronavirus.